Skip to main content
Quest Diagnostics

Assessing Alzheimer's Disease Risk in Primary Care Settings

Assessing Alzheimer's Disease Risk in Primary Care Settings Through Blood-based Biomarkers

The objectives of this webinar include:

 

•  Discuss the rising prevalence of Alzheimer’s disease

 

•  Outline current challenges in assessing and monitoring Alzheimer’s disease

 

•  Illustrate the role of blood-based biomarkers in primary care settings

 

•  Explore emerging treatments and new diagnostic pathways

 

Date:
Jun 08, 2022
Location:
Virtual - LIVE Webinar
Presenter(s):
Dr Michael K. Racke & Dr Roberto Fernandez-Romero 
Moderator(s):
Gabriele Olla

Related content

On-Demand Webinar
Revolutionizing Alzheimer’s Disease Clinical Trials Using a Blood-Based Diagnostic Test for Participant Identification
On-Demand Webinar
The Emerging Role of Blood-based Biomarkers in Alzheimer's Disease
Audio Podcast
Alzheimer’s disease: A new generation of screenings and therapies on the horizon

Michael K. Racke, MD

Roberto Fernandez-Romero, MD, MPH, PhD

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.